Australian Life Sciences Stock News

ALS recently reported record FY26 results, underpinned by strength in its Commodities segment and mixed outcomes in Life Sciences, while its shares went ex-dividend on 12 June for a final A$0.231 per share payout and the company was added to the S&P/ASX 50 index effective 22 June. This combination of index inclusion, dividend distribution, and strong operational performance highlights how both capital flows and business fundamentals are shaping ALS’s current profile. With ALS’s record FY26...

Santos has recently reached first oil at its Pikka Phase 1 project in Alaska and continued progressing its Barossa LNG and domestic gas initiatives, while outlining capital plans aimed at cutting net debt by US$2.50 billion by 2030 and prioritising LNG and oil assets in Alaska, Papua New Guinea and Australia. This combination of new production, long-term gas sales agreements and a sharper focus on debt reduction and core LNG and oil projects could meaningfully influence how investors assess...

APA Group recently shifted its capital allocation by stepping back from a major renewable energy zone project, while reiterating plans to keep investing in gas transmission and generation to support energy security and firm renewable output. This recalibration highlights how APA is trying to balance long-term decarbonization ambitions with near-term reliance on gas infrastructure, accepting higher operational emissions today to underpin reliable cash flows and system stability. We’ll now...

Metcash (ASX:MTS) issued FY26 earnings guidance alongside a new cost reduction program. This combination coincided with a 5.72% share price move and renewed interest in this consumer staples stock. See our latest analysis for Metcash. Beyond the immediate reaction to FY26 guidance, Metcash’s recent strength, including a 30 day share price return of 8.08% and a 90 day share price return of 8.08%, contrasts with a year to date share price decline of 3.02% and a 1 year total shareholder return...

Macquarie Group (ASX:MQG) is back in focus after delivering a strong full-year earnings result, with profit rises across all four divisions and a declared final dividend. This has coincided with fresh interest in ASX financial stocks. See our latest analysis for Macquarie Group. Macquarie Group's 1 day share price return of 2.80% and 90 day share price return of 24.12% have lifted the stock near its highs at A$242.44. A 5 year total shareholder return of 86.94% shows sustained investor...

Earlier this week, SRG Global announced it had secured A$1.85 billion in new contracts across water, defence, energy and health, while lifting its FY26 EBITDA guidance to the top of its prior range and issuing FY27 guidance above market expectations. The breadth of these wins across critical infrastructure segments highlights how SRG Global’s diversified capabilities are being tapped for complex, long-duration projects that can reinforce its recurring earnings base. Now we’ll examine how SRG...

Aristocrat Leisure (ASX:ALL) has extended its on-market share buy-back program to A$2.5b, alongside reporting 8.4% growth in normalised NPATA, an interim unfranked dividend, and further market share gains. See our latest analysis for Aristocrat Leisure. The recent buy-back extension and earnings update come after a mixed share price run, with Aristocrat Leisure’s stock gaining 16.71% over 90 days but remaining down 5.78% on a year-to-date share price return and delivering a 14.26% decline in...

Exploration update around Boda Kaiser puts Alkane Resources (ASX:ALK) in focus Alkane Resources (ASX:ALK) is back on investors radars after reporting fresh exploration results from the Northern Molong Porphyry Project in New South Wales, including new drilling between its Boda and Kaiser deposits. See our latest analysis for Alkane Resources. The latest drilling update lands after a mixed price pattern, with the share price up 2.9% over the last day to A$1.415 but down 9% on a 30 day share...

Perenti’s Barminco subsidiary recently secured an underground mining contract with Bellevue Gold valued at about A$850 million, commencing 1 August with an option for a 12‑month extension. This win, alongside the 1 June appointment of Vanessa Torres as managing director and chief executive, underscores Perenti’s focus on expanding higher‑value underground mining services in Australia. We’ll now examine how this sizeable Bellevue Gold contract influences Perenti’s existing investment...

REA Group (ASX:REA) is back in focus after multiple broker downgrades and renewed scrutiny of Australia’s proposed tax changes, with investors weighing the risk of softer listing volumes against the company’s recent A$200 million buyback completion. See our latest analysis for REA Group. At A$143.0, the stock has fallen about 16% on a 30 day share price return basis and is down 22.61% year to date. The 1 year total shareholder return of a 37.67% decline contrasts with a 7.41% gain over three...

CSL has recently cut its FY26 revenue and profit forecasts following earnings downgrades, writedowns and impairments tied to shifts in US immunoglobulin sales channels and softer China albumin prices, ahead of its full-year results and dividend announcement previously scheduled for 18 August 2026. Despite these setbacks, investors appear increasingly focused on CSL’s turnaround prospects and the possibility that future impairments could be more contained than previously feared. We’ll now...

Earlier this month, Wesfarmers announced that its Industrial and Safety businesses, Blackwoods and Workwear Group, will be folded into Bunnings Group from 1 July 2026, aligning complementary customer bases while expecting stronger customer value propositions, incremental sales and cost efficiencies with minimal one-off transition costs. The move also coincides with the planned retirement of Industrial and Safety Managing Director Tim Bult and underscores Wesfarmers’ broader 2026 Strategy Day...

In May 2026, GQG Partners reported a sixth consecutive month of net outflows, with funds under management slipping to US$163.3 billion from US$166.9 billion, as industry scrutiny of active equity strategies persisted. Because GQG’s high, largely unfranked US dollar dividend relies heavily on stable funds under management, these ongoing outflows sharpen investor focus on how secure its income engine really is. We’ll now examine how this pattern of net outflows, against a backdrop of a high...

Develop Global recently approved final investment decisions for its Sulphur Springs copper-zinc and Pioneer Dome lithium projects, underpinned by a US$400 million funding package from Trafigura that includes a US$350 million loan facility, a US$50 million warrant package and binding offtake agreements. This combination of project commitments, long-term offtake and structured financing marks a major step in Develop Global’s shift toward being a multi-commodity producer with both mining...

Ramelius Resources (ASX:RMS) has been in focus after its share price reacted to weaker gold prices and the company reaffirmed its FY26 production guidance midpoint while lifting all in sustaining cost estimates. See our latest analysis for Ramelius Resources. At around A$3.01, Ramelius has seen its share price fall 15.9% over the past 30 days and 28.8% year to date, even though its 3 year total shareholder return is very large. This suggests recent share price momentum has cooled despite...

If you are wondering whether Lynas Rare Earths at around A$17.77 still offers value, the key is to understand what the current share price actually builds in. The stock has pulled back recently, with the price declining 2.1% over the past week and 10.7% over the past month, although it is still up 45.4% year to date and 97.4% over the last year. Those moves have kept Lynas Rare Earths firmly on investor watchlists as one of the more closely followed rare earth producers, particularly given...

Guzman y Gomez's index removal puts focus on stock fundamentals Guzman y Gomez (ASX:GYG) is set to be removed from the S&P/ASX 200 index before 22 June 2026 after recent underperformance relative to the broader market and a heavier index tilt toward resource and other priority sectors. The reshuffle is expected to prompt selling by index funds that track the benchmark, which can affect short term trading volumes and liquidity. This places greater emphasis on Guzman y Gomez’s earnings profile...

Earlier this week, Sunrise Energy Metals drew attention as it progressed toward a final investment decision on its Syerston scandium project, supported by a multi‑year scandium oxide supply option with Lockheed Martin. The combination of advancing a critical minerals project timeline and securing interest from a major aerospace and defense contractor has sharpened focus on Sunrise Energy Metals’ role in future scandium supply chains. Next, we’ll examine how the Lockheed Martin supply option...

Goodman Group (ASX:GMG) is back in focus after its shares rose 1.57% despite a recent director share sale, with attention centred on the group’s growing global data centre development pipeline. See our latest analysis for Goodman Group. At A$31.52, the stock’s recent 2.24% 1 day share price return and strong 22.6% 90 day share price return suggest momentum has been building, even though the 1 year total shareholder return is down 6.38% and the 5 year total shareholder return is 60.19%. If...

Earlier in June 2026, Bank of Queensland reported its first-half FY26 results showing a 20% decline in statutory profit, driven by margin compression, higher costs, and increased credit expenses, while highlighting moderating economic growth and persistent inflation pressures. At the same time, management emphasised a strong capital position that could support a share buyback and special dividend, drawing attention to how capital management may offset operating headwinds. We’ll now examine...

Telix Pharmaceuticals recently reported Part 1 data from its ProstACT Global Phase 3 trial in metastatic castration-resistant prostate cancer, showing TLX591-Tx had an acceptable safety and tolerability profile with no new safety signals when combined with standard-of-care therapies. The findings underline a potentially differentiated safety profile versus existing PSMA-targeted radioligand therapies, with lower kidney and salivary gland exposure that may be clinically meaningful for...

FireFly Metals (ASX:FFM) is set to join the S&P/ASX 200 index from 22 June 2026, a milestone that can draw fresh attention from index funds and broaden the stock’s institutional shareholder base. See our latest analysis for FireFly Metals. At the latest share price of A$1.905, FireFly Metals has had a mixed few months, with the share price down 11% over 30 days but up 9% over 90 days, while the 1 year total shareholder return of 84.95% points to strong longer term momentum that recent index...

The recent price decline of 11% in Pureprofile Ltd's ( ASX:PPL ) stock may have disappointed insiders who bought...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...